Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -10.96M | -12.46M | -14.91M | -16.09M | -14.47M |
| Total Depreciation and Amortization | 12.70K | 12.80K | -247.00K | 10.40K | 18.70K |
| Total Amortization of Deferred Charges | 0.00 | 1.37M | 4.77M | 6.47M | 6.47M |
| Total Other Non-Cash Items | 1.21M | 1.28M | 757.60K | 595.70K | 432.60K |
| Change in Net Operating Assets | 421.60K | 34.10K | 490.30K | 1.07M | 272.50K |
| Cash from Operations | -9.32M | -9.76M | -9.13M | -7.95M | -7.28M |
| Capital Expenditure | -21.40K | -13.30K | -11.30K | -17.20K | -13.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -1.62M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -400.00K | -400.00K | -400.00K | 1.37M |
| Cash from Investing | -21.40K | -413.30K | -411.30K | -417.20K | -263.60K |
| Total Debt Issued | 0.00 | 0.00 | 3.00M | 6.00M | 6.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 18.84M | 18.84M | 18.84M | 18.84M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.55M | -1.79M | -2.30M | -2.30M |
| Cash from Financing | 0.00 | 17.29M | 20.05M | 22.53M | 22.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.34M | 7.11M | 10.50M | 14.17M | 14.99M |
